Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-029136
Filing Date
2020-10-22
Accepted
2020-10-22 21:03:05
Documents
2
Period of Report
2020-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2692
2 EX-24 DOCUMENT attachment1.htm EX-24 4047
  Complete submission text file 0000899243-20-029136.txt   8119
Mailing Address C/O BROOKSIDE CAPITAL, LLC JOHN HANCOCK TOWER, 200 CLARENDON ST BOSTON MA 02116
Business Address
Koppel Adam (Reporting) CIK: 0001578965 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39634 | Film No.: 201255874

Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Issuer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations